Leading Point-of-Care tests developer, which intends to help Chinese people cut healthcare cost by providing low-cost but high-quality in-vitro diagnostic tests to doctors, especially those at small hospitals and clinics. Starting from developing TB-Triple - the world-leading IVD test for Tuberculosis, BioHermes now aims to serve more people by expanding pipeline into Ob&G and Diabetes.